Key result
Streptozotocin-induced diabetes mellitus in rats significantly depressed cardiac sarcolemmal Ca2+ pump activity compared to controls.
Population
Male Wistar rats, 8 weeks after streptozotocin injection (55 mg/kg iv) to induce diabetes mellitus
Comparison
Streptozotocin-induced diabetes mellitus vs Non-diabetic control rats
Design
Preclinical
Follow-up
8 weeks
Authors
Loading...
Should not change clinical practice; leaves open whether sarcolemmal Ca2+ pump dysfunction contributes to human diabetic cardiomyopathy.
The sarcolemmal Ca2+ pump is defective in the diabetic myocardium, which may contribute to altered Ca2+ transport and the development of diabetic cardiomyopathy.
Heyliger et al. (1987) studied Diabetes mellitus. Streptozotocin-induced diabetes mellitus vs. Controls was evaluated on Ca2+ pump activity (Ca2+-stimulated adenosine triphosphatase and Ca2+-uptake ability). Streptozotocin-induced diabetes mellitus in rats significantly depressed cardiac sarcolemmal Ca2+ pump activity compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: